Semax nasal spray is a synthetic peptide that has been studied in scientific research for its potential effects on neurological function. Originally developed for research in Russia, Semax is not approved as a licensed medicine in the United Kingdom by the Medicines and Healthcare products Regulatory Agency (MHRA).
Products marketed as Semax nasal spray in the UK are generally supplied for research purposes only. Their quality, composition, and regulatory status may vary depending on the supplier. Researchers and purchasers should carefully review product documentation, storage requirements, batch information, and applicable regulations before obtaining or handling any research peptide.
Product Information
- Synthetic peptide supplied for laboratory research
- Typically formulated as a nasal spray for research applications
- Intended for qualified research professionals
- Batch and product specifications may vary by manufacturer
- Store according to the supplier’s recommended conditions
Important Notice
Semax nasal spray is not approved for human therapeutic use in the UK. It is not intended to diagnose, treat, cure, or prevent any disease and should not be marketed or represented as a licensed medicine. Any use should comply with applicable laws, regulations, and institutional research policies.
Always verify the regulatory status of research peptides and purchase only from reputable suppliers that provide appropriate product documentation and quality information.




Reviews
There are no reviews yet.